# Naegis Pharmaceuticals Inc. — Form D

Naegis Pharmaceuticals Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-02. The offering totals $351K, of which $351K was reported sold. Industry: Other.

## Offering

- Filed: 2024-05-02
- Form: D
- Accession: 0002021578-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $351K
- Amount sold: $351K
- Investors: 4
- Date of first sale: 2024-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-512157

## Issuer

- Name: Naegis Pharmaceuticals Inc.
- CIK: 0002021578
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 999 WEST BROADWAY, VANCOUVER, A1, V5Z 1K5
- Phone: 604-235-1682

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| David Burgoyne | Director | Vancouver, A1 |
| Philip Davies | Director | Vancouver, A1 |
| Julian Gangolli | Director | Iselin, NJ |
| Cameron Groome | Director | Markham, A6 |
| Michael Liggett | Director | Vancouver, A1 |
| Ian McBeath | Director | Vancouver, A1 |
| David Burgoyne | Executive Officer | Vancouver, A1 |
| Ian McBeath | Executive Officer | Vancouver, A1 |

## More

- [CIK 2021578 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2021578&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002021578-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.